Ildong Pharmaceutical Co., Ltd.
249420.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
461
Cost of Revenue
286
Gross Profit
175
Gross Margin
38.0%
Operating Income
10
Operating Margin
2.1%
Net Income
-3
Net Margin
-0.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
25
EBITDA Margin
5.5%
2023
12/31/2023
Revenue
451
Cost of Revenue
295
Gross Profit
156
Gross Margin
34.5%
Operating Income
-40
Operating Margin
-8.9%
Net Income
-59
Net Margin
-13.1%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
-38
EBITDA Margin
-8.5%
2022
12/31/2022
Revenue
478
Cost of Revenue
301
Gross Profit
177
Gross Margin
37.1%
Operating Income
-55
Operating Margin
-11.5%
Net Income
-107
Net Margin
-22.3%
EPS (Basic)
$-4.00
EPS (Diluted)
$-4.00
EBITDA
-60
EBITDA Margin
-12.6%
2021
12/31/2021
Revenue
420
Cost of Revenue
256
Gross Profit
165
Gross Margin
39.2%
Operating Income
-41
Operating Margin
-9.7%
Net Income
-75
Net Margin
-17.8%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
-76
EBITDA Margin
-18.1%
2020
12/31/2020
Revenue
421
Cost of Revenue
243
Gross Profit
179
Gross Margin
42.4%
Operating Income
5
Operating Margin
1.2%
Net Income
-10
Net Margin
-2.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
17
EBITDA Margin
4.0%